Tumor News and Research

RSS

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Compugen Ltd., a leading predictive drug discovery company, today presented new data for its preclinical CGEN-15029 program demonstrating the potential for the development of new cancer immunotherapy treatments for solid tumors, including the potential for drug combination with current immune checkpoint blockers.

11 Nov 2016

Technion researchers develop new diagnostic technology for improving personalized cancer treatment

Using synthetic DNA sequences as the tiniest of barcodes, Technion researchers have developed a new diagnostic technology for determining the suitability of specific anticancer drugs to a specific patient - before treatment even begins.

11 Nov 2016

NSU researchers learn more about Gulf War illness to help veterans

As the nation honors our veterans on November 11, we must pause to remember the long-lasting health effects soldiers experience not only from bullets or bombs, but from exposure to unexplained pesticides, radiation or other toxins during their time in the service.

11 Nov 2016

Women with higher vitamin D levels have better long-term outcomes after breast cancer diagnosis

Women with higher vitamin D levels in their blood following a breast cancer diagnosis had significantly better long-term outcomes, according to new research from Kaiser Permanente and Roswell Park Cancer Institute.

11 Nov 2016

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Meningiomas are the most common primary brain tumors, but the term encompasses over a dozen subtypes that range from benign to highly aggressive.

10 Nov 2016

Scientists uncover how common Epstein-Barr virus causes blood cancer in adults and children

Scientists at the University of Sussex, trying to uncover how the common Epstein-Barr virus causes blood cancer in adults and children, have discovered how the virus takes control of two genes involved in cancer development so it can switch them on or off.

10 Nov 2016

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East.

10 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Scientists show how key protein can be important driver of prostate cancer

Scientists at The Wistar Institute have demonstrated how a protein called TRAP1 - an important regulator of energy production in healthy and cancerous cells - is an important driver of prostate cancer and appears to be a valuable therapeutic target for the disease.

9 Nov 2016

Scientists discover new mechanism responsible for regulation of glucose metabolism

Diabetes mellitus is a chronic disease that has become increasingly prevalent in the population: More than six million people are affected by the disease alone in Germany.

9 Nov 2016

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, announced it has entered into an exclusive license agreement with the University of Florida, Gainesville to develop a novel oncolytic virus platform.

8 Nov 2016

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

SMU virologist and cancer researcher Robert L. Harrod has been awarded a $436,500 grant from the National Cancer Institute to further his lab's research into how certain viruses cause cancers in humans.

8 Nov 2016

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy - a new approach to treating cancer by boosting a patient's immune system -- may fail in a substantial number of patients.

8 Nov 2016

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs.

8 Nov 2016

UPCI scientists reveal how cancer cells hijack DNA repair pathways to stay alive

Research by scientists at the University of Pittsburgh Cancer Institute has revealed how cancer cells hijack DNA repair pathways to prevent telomeres, the endcaps of chromosomes, from shortening, thus allowing the tumor to spread. The findings are published today in the journal Cell Reports.

8 Nov 2016

Caltech researchers develop new technique that increases safety of TCR gene therapy

The human body produces T cells to recognize and fight disease. Each T cell has a unique T cell receptor (or TCR) on its surface that surveils small fragments of proteins presented by other cells.

8 Nov 2016

Researchers discover signaling pathway that can stop brain tumor formation in animal models

A research team at the Krembil Research Institute has discovered that a signaling pathway which controls blood vessel development in the brain has the ability to stop brain tumor formation in animal models of medulloblastoma, the most common malignant brain tumor diagnosed in children.

8 Nov 2016

Tumor News and Research

Compugen program shows potential for development of new immunotherapy treatments for solid tumors

Technion researchers develop new diagnostic technology for improving personalized cancer treatment

NSU researchers learn more about Gulf War illness to help veterans

Women with higher vitamin D levels have better long-term outcomes after breast cancer diagnosis

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Scientists uncover how common Epstein-Barr virus causes blood cancer in adults and children

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Scientists show how key protein can be important driver of prostate cancer

Scientists discover new mechanism responsible for regulation of glucose metabolism

DNAtrix enters into license agreement with University of Florida to develop new oncolytic virus platform

SMU virologist receives NCI grant to advance research into how certain viruses cause cancers

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

UPCI scientists reveal how cancer cells hijack DNA repair pathways to stay alive

Caltech researchers develop new technique that increases safety of TCR gene therapy

Researchers discover signaling pathway that can stop brain tumor formation in animal models

Researchers unravel puzzle of necroptosis

Researchers uncover possible targeted therapy for new, high-risk subtype of ALL

Study finds lack of improvement in health status of childhood cancer survivors

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News